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Lessons From Optimal Coherence TomographyKatsumasa Sato, MD,* Vasileios F. Panoulas, PHD,*y Hiroyoshi Kawamoto, MD,* Toru Naganuma, MD,*
Tadashi Miyazaki, MD,* Azeem Latib, MD,* Antonio Colombo, MD*T here are limited data regarding the sidebranch occlusion (SBO) after Absorb bioresor-bable everolimus-eluting vascular scaffolds
(BVS) 1.1 (Abbott Vascular, Santa Clara, California).
Even though the second-generation BVS 1.1 has im-
proved on the design of BVS 1.0, the increased strut
thickness and width remain and potentially more
frequently compromise small SB as compared to the
new-generation drug-eluting stents with thin strut. A
previous study (1) demonstrated that BVS had a higher
incidence (10.5%) of post-procedural SBO compared
with the everolimus-eluting metallic stent for SB with
a reference vessel diameter #0.5 mm. Regarding SB
with a reference vessel diameter of$1.0mm, however,
the incidence of SBO in the BVS group was similar to
that in the everolimus-eluting metallic stent group
(1.7% vs. 2.2%, p¼0.61).
The current case report demonstrates the inter-
esting ﬁnding of SBO after BVS implantation for a
bifurcation lesion. A 69-year-old man was referred
to our hospital for coronary angiography as he had
been experiencing worsening exertional angina. An-
giogram revealed a signiﬁcant stenosis at a bifurcation
site in the distal left circumﬂex artery (Medina class
1.1.1) (Figures 1A and 1B). According to quantitative
coronary analysis, RVD and minimal lumen diameter
of SB1 was 2.30 mm and 0.82 mm, respectively. A BVS
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a guidewire in the side branch. Subsequently, the jailed
guidewire in the side branch was removed to reduce
the artifacts during optical coherence tomography
(OCT), aiming to evaluate the scaffold expansion
and apposition. However, angiogram following OCT
evaluation revealed a SBO (Figures 1C and 1D). Several
attempts to recross with the guidewire through the
BVS strut into the SB were unsuccessful. The OCT
demonstrated that the oriﬁces of both SB1 and SB2
were completely covered by the BVS struts (Figures 2A
to 2C). According to OCT ﬁndings, the main cause
of SBO in this case may have been the increased
BVS strut thickness and width rather than other
well-known causes of SB compromise. Previous
studies suggested several potential mechanisms for
SBO, including the presence of ostial stenosis in the
SB, dissection, plaque, and carina shift (2,3). In this
case, however, the BVS struts alone appear to be the
cause of SBO. Therefore, operators should be aware of
the possibility of SBO when treating the main vessel
with a BVS, even in SB with reference vessel diameters
of more than 1.0 mm.
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FIGURE 1 Coronary Angiogram of the Left Coronary System
Angiogram before percutaneous coronary intervention showed signiﬁcant stenosis at the bifurcation in the distal left circumﬂex artery (Medina
class 1.1.1) (A, B). According to quantitative coronary analysis, reference vessel diameter and minimal lumen diameter of SB1 was 2.30 mm and
0.82 mm, respectively. Angiogram after implantation of a bioresorbable vascular scaffold in the distal left circumﬂex (C, D). Side branches (SB1
and SB2) were occluded after scaffold implantation. BVS ¼ bioresorbable vascular scaffold; MB ¼ main branch.
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FIGURE 2 Pre- and Post-Procedural Angiographic Findings and OCT Findings After Scaffold Implantation
Optical coherence tomography (OCT) imaging showed that the bioresorbable vascular scaffold struts covered completely the oriﬁce of side
branches (SB1 and SB2) (A to C), despite the bioresorbable vascular scaffold being well expanded with no malapposition and an acceptable
lumen area. Abbreviations as in Figure 1.
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